Doong S L, Dolnick B J
Department of Human Oncology, University of Wisconsin at Madison 53792.
J Biol Chem. 1988 Mar 25;263(9):4467-73.
We are interested in determining whether incorporation of the drug 5-fluorouracil into pre-mRNA can alter RNA processing. The effect of 5-fluorouracil (FUra) substitution on the in vitro splicing of pre-mRNA was studied. 32P-Labeled human beta-globin pre-mRNA containing the first two exons and the first intervening sequence was synthesized in the presence of UTP, FUTP, or both. In vitro splicing reactions generated several abnormal intermediates and products from FUra-substituted transcripts. The appearance of a new minor spliced product was dependent on both the pH of the splicing reaction and the extent of FUra incorporation into pre-mRNA. Abnormal splicing was observed at pH 8.4 and 7.7 but not at pH 6.7. The new minor spliced product was sequenced and found to contain an additional 20 bases derived from the 3'-end of the intervening sequence. The abnormally migrating intermediate had the same structure as the normal lariat-exon intermediate. These results suggest that FUra substitution into pre-mRNA can alter splicing in vitro.
我们感兴趣的是确定将药物5-氟尿嘧啶掺入前体mRNA是否会改变RNA加工过程。研究了5-氟尿嘧啶(FUra)取代对前体mRNA体外剪接的影响。在UTP、FUTP或两者存在的情况下,合成了含有前两个外显子和第一个内含序列的32P标记的人β-珠蛋白前体mRNA。体外剪接反应从FUra取代的转录本中产生了几种异常中间体和产物。一种新的小剪接产物的出现取决于剪接反应的pH值和FUra掺入前体mRNA的程度。在pH 8.4和7.7时观察到异常剪接,但在pH 6.7时未观察到。对新的小剪接产物进行测序,发现其包含来自内含序列3'端的另外20个碱基。异常迁移的中间体与正常套索状外显子中间体具有相同的结构。这些结果表明,将FUra取代到前体mRNA中可在体外改变剪接。